Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide, characterized by accumulation of fat in the liver cells in people who drink little to no alcohol. Its prevalence is escalating, in tandem with the global rise in obesity and type 2 diabetes, making it a significant concern for healthcare providers.
Prevention strategies primarily revolve around lifestyle modifications. Encouraging patients to adopt a balanced diet, increase physical activity, and achieve a healthy body weight can significantly reduce the risk of developing NAFLD. Regular screening for metabolic risk factors such as hyperlipidemia, hypertension, and diabetes is also crucial in early detection and prevention.
Diagnosis of NAFLD involves a combination of medical history, physical examination, and laboratory tests. Imaging techniques such as ultrasound, CT, and MRI can be used to detect fatty liver, while liver biopsy remains the gold standard for diagnosing and staging NAFLD. Non-invasive tests, including transient elastography and serum biomarkers, are emerging as promising tools for diagnosing and monitoring disease progression.
Currently, there is no approved pharmacological therapy for NAFLD. The mainstay of treatment is lifestyle modification aimed at weight loss. In patients with NASH, vitamin E and pioglitazone have shown benefits. For advanced disease, liver transplantation may be considered. Ongoing research is focused on developing targeted therapies to address the underlying pathophysiology of NAFLD.
NAFLD is a growing health concern that necessitates proactive prevention, early detection, and effective management strategies. Healthcare professionals play a pivotal role in this endeavor. Keeping abreast of the latest research and advances in the field will ensure optimal patient care and outcomes in managing this complex disease.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation